BMY Analyst Insights | BRISTOL-MYERS SQUIBB COMPANY

Ratings	Buy	Hold	Sell	Other ratings	Last Close	Average Target	Upside	High Target	Low Target
(m)	(m)	(m)	(m)	(m)	$62.14	(m)	(m)	(m)	(m)

Date	Stock	Analyst	Firm	Price When Rated	Price Target	Upside / Downside	Rating
2026-02-19	BMY BRISTOL MYERS SQUIBB CO	Emily Field, CFA	Barclays	$60.35	$75.00	+24.28%	Overweight
2024-11-29	BMY BRISTOL MYERS SQUIBB CO	Emily Field, CFA	Barclays	$59.27			Underweight
2024-10-04	BMY BRISTOL MYERS SQUIBB CO	Emily Field, CFA	Barclays	$54.20	$43.00	-20.66%	Underweight
2024-08-21	BMY BRISTOL MYERS SQUIBB CO	Emily Field, CFA	Barclays	$48.98	$42.00	-14.25%	Underweight
2024-07-29	BMY BRISTOL MYERS SQUIBB CO	Emily Field, CFA	Barclays	$50.45			Underweight
2024-07-10	BMY BRISTOL MYERS SQUIBB CO	Emily Field, CFA	Barclays	$40.86	$41.00	+0.34%	Equal Weight
2024-04-25	BMY BRISTOL MYERS SQUIBB CO	Emily Field, CFA	Barclays	$44.70	$43.00	-3.80%	Equal Weight
2023-10-26	BMY BRISTOL MYERS SQUIBB CO	Emily Field, CFA	Barclays	$52.97	$51.00	-3.72%	Equal Weight
2023-10-02	BMY BRISTOL MYERS SQUIBB CO	Emily Field, CFA	Barclays	$57.85	$60.00	+3.72%	Equal Weight

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
VERTEX PHARMACEUTICALS INC / MA (VRTX)	United States	$132.481B	28.56
PFIZER INC (PFE)	United States	$162.042B	31.94
ABBOTT LABORATORIES (ABT)	United States	$176.045B	28.47
REGENERON PHARMACEUTICALS, INC. (REGN)	United States	$74.751B	21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)	United States	$33.420B	54.94
Zoetis Inc. (ZTS)	United States	$29.045B	11.38
INSMED Inc (INSM)	United States	$26.566B	-26.60
Roivant Sciences Ltd. (ROIV)		$26.105B	-96.08
Royalty Pharma plc (RPRX)	United States	$22.628B
UNITED THERAPEUTICS Corp (UTHR)	United States	$20.249B	17.64